• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前SOFT评分、P-SOFT评分、SALT评分及实验室MELD评分对移植前实验室MELD评分≥30的高危肝移植受者短期患者及移植物存活预测的价值

Value of the preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the prediction of short-term patient and graft survival of high-risk liver transplant recipients with a pre-transplant labMELD-score ≥30.

作者信息

Reichert Benedikt, Becker Thomas, Weismüller Tobias J, Kleine Moritz, Zachau Lea, Johanning Kai, Lehner Frank, Klempnauer Jürgen, Schrem Harald

机构信息

General, Visceral and Transplantation Surgery, Hanover Medical School, Germany.

出版信息

Ann Transplant. 2012 Apr-Jun;17(2):11-7. doi: 10.12659/aot.883218.

DOI:10.12659/aot.883218
PMID:22743718
Abstract

BACKGROUND

The SOFT-score, P-SOFT-score, SALT-score and labMELD-score have been applied for the prediction of survival of liver transplant recipients after transplantation. We analysed the value of these scores for the prediction of short-term survival in high-risk liver transplant recipients with a labMELD-score ≥30.

MATERIAL/METHODS: Retrospective single-centre analysis including 88 consecutive liver transplants in adults between 01.01.2007 and 31.12.2010 with a pretransplant labMELD-score ≥30 and follow-up until the 31.12.2011. Combined and living-related liver transplants were excluded. ROC-curve analysis was used to calculate sensitivity, specificity and overall model correctness of prognostic models.

RESULTS

The P-SOFT-score demonstrated a significant influence on 1-year patient survival (p=0.045, Mann-Whitney-U test). Multivariate Cox regression analysis showed a significant influence of the P-SOFT-score on patient (p=0.013; Exp(B)=1.050; 95%CI: 1.010-1.091) and on graft survival (p=0.023; Exp(B)=1.042; 95%CI: 1.006-1.080). ROC-curve analysis showed areas under the curve (AUROCs) <0.5 for the SOFT-score, P-SOFT-score, SALT-score and the labMELD-score ≥30 for the prediction of 3-month patient and graft survival as well as 1-year patient and graft survival.

CONCLUSIONS

Our results imply that the SOFT-score, P-SOFT-score, SALT-score and labMELD-score ≥30 all have a sensitivity, specificity and overall model correctness that is unable to discriminate short-term survivors from non-survivors in a collective of high-risk liver transplant recipients sufficiently in order to guide clinical decision making in the current German transplant situation with decreasing numbers of deceased liver donors, decreasing donor organ quality and increasingly sick transplant candidates.

摘要

背景

SOFT评分、P-SOFT评分、SALT评分和实验室MELD评分已用于预测肝移植受者移植后的生存情况。我们分析了这些评分对实验室MELD评分≥30的高风险肝移植受者短期生存预测的价值。

材料/方法:回顾性单中心分析,纳入2007年1月1日至2010年12月31日期间连续88例成年肝移植患者,移植前实验室MELD评分≥30,并随访至2011年12月31日。排除联合肝移植和活体亲属肝移植。采用ROC曲线分析计算预后模型的敏感性、特异性和整体模型正确性。

结果

P-SOFT评分对患者1年生存率有显著影响(p=0.045,Mann-Whitney-U检验)。多因素Cox回归分析显示,P-SOFT评分对患者生存率(p=0.013;Exp(B)=1.050;95%CI:1.010-1.091)和移植物生存率(p=0.023;Exp(B)=1.042;95%CI:1.006-1.080)有显著影响。ROC曲线分析显示,SOFT评分、P-SOFT评分、SALT评分以及实验室MELD评分≥30用于预测3个月患者和移植物生存率以及1年患者和移植物生存率时,曲线下面积(AUROCs)<0.5。

结论

我们的结果表明,在德国目前肝移植供体数量减少、供体器官质量下降以及移植候选者病情日益严重的移植情况下,SOFT评分、P-SOFT评分、SALT评分和实验室MELD评分≥30的敏感性、特异性和整体模型正确性均不足以充分区分高风险肝移植受者群体中的短期生存者和非生存者,从而指导临床决策。

相似文献

1
Value of the preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the prediction of short-term patient and graft survival of high-risk liver transplant recipients with a pre-transplant labMELD-score ≥30.术前SOFT评分、P-SOFT评分、SALT评分及实验室MELD评分对移植前实验室MELD评分≥30的高危肝移植受者短期患者及移植物存活预测的价值
Ann Transplant. 2012 Apr-Jun;17(2):11-7. doi: 10.12659/aot.883218.
2
Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30.SOFA 评分作为移植前 labMELD 评分≥30 的高危肝移植受者短期生存预测模型的价值。
Langenbecks Arch Surg. 2012 Jun;397(5):717-26. doi: 10.1007/s00423-011-0881-9. Epub 2011 Dec 6.
3
The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity.供体风险指数、ECD评分和D-MELD评分均无法以可接受的敏感性和特异性预测肝移植后的短期预后。
Ann Transplant. 2012 Jul-Sep;17(3):5-13. doi: 10.12659/aot.883452.
4
Defining long-term outcomes with living donor liver transplantation in North America.界定北美活体供肝移植的长期预后。
Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.
5
UNOS Liver Registry: ten year survivals.器官共享联合网络肝脏登记处:十年生存率
Clin Transpl. 2006:29-39.
6
Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.终末期肝病模型评分40分及以上的肝移植受者的生存结局:十年经验
HPB (Oxford). 2015 Dec;17(12):1074-84. doi: 10.1111/hpb.12485. Epub 2015 Sep 16.
7
The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases.终末期肝病模型(MELD)评分可预测原发性硬化性胆管炎或自身免疫性肝病患者肝移植后的短期和总体生存率。
Langenbecks Arch Surg. 2014 Dec;399(8):1001-9. doi: 10.1007/s00423-014-1237-z. Epub 2014 Aug 9.
8
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.终末期肝病模型评分不能预测活体肝移植受者的患者或移植物存活率。
Liver Transpl. 2003 Jul;9(7):737-40. doi: 10.1053/jlts.2003.50122.
9
Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.成年受者中全肝移植、劈离式肝移植与活体供肝移植的比较:按移植类型分析结局
Transplantation. 2008 May 27;85(10):1420-4. doi: 10.1097/TP.0b013e31816de1a3.
10
Value and limitations of the BAR-score for donor allocation in liver transplantation.肝脏移植供体分配中BAR评分的价值与局限性
Langenbecks Arch Surg. 2014 Dec;399(8):1011-9. doi: 10.1007/s00423-014-1247-x. Epub 2014 Sep 14.

引用本文的文献

1
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor.在一名住院的新冠病毒检测呈阳性的受者身上,使用一名感染了新冠病毒的供者进行肝移植。
Am J Transplant. 2021 Jul;21(7):2600-2604. doi: 10.1111/ajt.16548. Epub 2021 Mar 17.
2
Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.基于供体和受体特征的不同评分系统对活体肝移植术后结局预测的比较
PLoS One. 2015 Sep 17;10(9):e0136604. doi: 10.1371/journal.pone.0136604. eCollection 2015.
3
Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.
终末期肝病模型(MELD)时代老年肝移植受者的预后。
Ann Transplant. 2014 Sep 26;19:478-87. doi: 10.12659/AOT.890934.
4
Value and limitations of the BAR-score for donor allocation in liver transplantation.肝脏移植供体分配中BAR评分的价值与局限性
Langenbecks Arch Surg. 2014 Dec;399(8):1011-9. doi: 10.1007/s00423-014-1247-x. Epub 2014 Sep 14.
5
High early cardiovascular mortality after liver transplantation.肝移植后早期心血管死亡率高。
Liver Transpl. 2014 Nov;20(11):1306-16. doi: 10.1002/lt.23950. Epub 2014 Oct 24.
6
Prognostic limitations of the Eurotransplant-Donor Risk Index in liver transplantation.欧洲移植供体风险指数在肝移植中的预后局限性
J Negat Results Biomed. 2013 Dec 24;12:18. doi: 10.1186/1477-5751-12-18.